Merck & Co. Inc. buy BMO Capital Markets
Start price
27.10.23
/
50%
€101.00
Target price
27.10.24
€125.02
Performance (%)
1.80%
Price
21:31
€100.00
Summary
This prediction is currently active. The BUY prediction by BMO_Capital_Markets shows slight gains of 1.80%. Dividends of €2.82 are taken into consideration when calculating the performance. This prediction currently runs until 27.10.24. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Merck & Co. Inc. | -0.988% | -0.988% |
iShares Core DAX® | -1.471% | 1.895% |
iShares Nasdaq 100 | -0.486% | 4.395% |
iShares Nikkei 225® | -2.115% | 2.450% |
iShares S&P 500 | 0.394% | 3.118% |
Comments by BMO_Capital_Markets for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $132.00 price target on the stock.
Ratings data for MRK provided by MarketBeat